Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant
Status:
Completed
Trial end date:
2009-06-10
Target enrollment:
Participant gender:
Summary
RATIONALE: Ondansetron may help lessen or prevent nausea and vomiting in patients undergoing
stem cell transplant.
PURPOSE: This phase II trial is studying how well ondansetron works in preventing nausea and
vomiting in patients undergoing stem cell transplant.